Differential Gene Regulation by PPARγ Agonist and Constitutively Active PPARγ2

Yong Li,Mitchell A. Lazar
DOI: https://doi.org/10.1210/mend.16.5.0825
2002-01-01
Molecular Endocrinology
Abstract:The PPARγ is a key adipogenic determination factor. Ligands for PPARγ such as antidiabetic thiazolidinedione (TZD) compounds are adipogenic, and many adipocyte genes that are activated by TZDs contain binding sites for PPARγ. Like ligands for other nuclear receptors, TZDs can regulate genes positively or negatively. Here, we sought to understand the importance of positive regulation of gene expression by PPARγ in adipogenesis. Fusion of the potent viral transcriptional activator VP16 to PPARγ2 (VP16-PPARγ) created a transcription factor that constitutively and dramatically activated transcription of PPARγ-responsive genes in the absence of ligand. Forced expression of VP16-PPARγ in 3T3-L1 preadipocytes using retroviral vectors led to adipogenesis in the absence of standard differentiating medium or any exogenous PPARγ ligand. Gene microarray analysis revealed that VP16-PPARγ induced many of the genes associated with adipogenesis and adipocyte function. Thus, direct up-regulation of gene expression by PPAR...
What problem does this paper attempt to address?